Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes

Author: Jang Won SON ¹
Author Information

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea
Publication Type:Editorial
From:Endocrinology and Metabolism 2021;36(1):57-59
CountryRepublic of Korea
Language:English